GlassScriptPhysician profile
Christopher W Rial
NPI 1174844310
$1,220.91
in general payments reported to CMS, 2019-2025
21 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $76.10 · 2021: $103 · 2022: $17.68 · 2023: $48.05 · 2024: $14.77 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $290.06 | 2019 | |
| Janssen Biotech, INC. | $168.72 | 2019 | |
| Pacira Therapeutics, INC. | $145.11 | 2019-2021 | |
| Bioventus LLC | $90.09 | 2019-2025 | Gelsyn-3 |
| E.R. Squibb & Sons, L.L.C. | $82.92 | 2019 | |
| Abbvie INC. | $47.38 | 2019 | |
| Celgene Corporation | $42.31 | 2019 | |
| Ucb, INC. | $40.53 | 2019 | |
| Glaxosmithkline, LLC. | $38.91 | 2019 | |
| Mallinckrodt Enterprises LLC | $38.68 | 2019 | |
| Depuy Synthes Sales INC. | $35.93 | 2019-2024 | Orthovisc, Monovisc |
| Lemaitre Vascular, INC. | $26.28 | 2025 | Restoreflow |
| Medtronic, INC. | $25.71 | 2023 | Venaseal |
| Horizon Therapeutics Plc | $22.60 | 2019 | |
| Gilead Sciences, INC. | $21.94 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $19.88 | 2025 | Puraply Wound Matrix |
| Ibsa Pharma INC. | $19.61 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.31 | 2025 | |
| Philips North America LLC | $17.22 | 2020 | |
| Zimmer Biomet Holdings, INC. | $16.76 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.